HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Cyclobenzaprine Hydrochloride

HCID 22576
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
6202-23-9
Standard SMILES
CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl
InChIKey
VXEAYBOGHINOKW-UHFFFAOYSA-N
Molecular formula
C20H22ClN
Average molar mass
311.8 g/mol
Monoisotopic mass
311.14407738

Overview

Cyclobenzaprine hydrochloride is the hydrochloride salt of cyclobenzaprine. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm. It has a role as an antidepressant and a muscle relaxant. It contains a cyclobenzaprine. It derives from a hydride of a dibenzo[a,d][7]annulene.

Names & identifiers

Preferred name
Cyclobenzaprine Hydrochloride
IUPAC
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride
English name
Cyclobenzaprine hydrochloride
Molecular formula
C20H22ClN
Molecular weight
311.85

Names & synonyms

Cyclobenzaprine hydrochloride6202-23-9Cyclobenzaprine HCLFlexerilFlexibanAmrixCycloflexClobenNovo-CycloprineTabradolTNX-102DTXSID2045105
Show more names
FlexibaLisserilCyclobezaprine HClMK130 hydrochlorideNortriptyline EP Impurity EAmitriptyline EP Impurity B
CYCLOBENZAPRINE HCI0VE05JYS2PNSC-78206NSC-169900NSC-17337910,11delta-Amitriptyline hydrochlorideCHEBI:3997DTXCID0025105

Database identifiers

CAS
6202-23-9
PubChem CID
22576
DTXSID
DTXSID2045105
ChEMBL
CHEMBL1200636
ChEBI
CHEBI:3997
UNII
0VE05JYS2P
EC Number
228-264-4

Properties

Computed structural properties

Topological polar surface area
3.2 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
1
Rotatable bonds
3
Heavy atoms
22
Formal charge
0
Complexity
365

Experimental & physicochemical properties

Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Muscle Relaxants, Central

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
216 · 216-2180C
Flash point
9 ℃ · 9℃
storage temp.
Inert atmosphere,Room Temperature
Water Solubility
Completely soluble in water
solubility
15.59 mg/mL · ≥15.59 mg/mL in DMSO; ≥5.32 mg/mL in EtOH; ≥54.3 mg/mL in H2O
form
Solid
color
White to Almost white
λmax
290 nm · 290nm(lit.)
Merck
14 · 14,2713
Major Application
pharmaceutical (small molecule)
InChI
1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 1.8% (1 of 55) of reports.

Danger

H301 (89.1%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P270, P271, P272, P280, P301+P316, P302+P352, P304+P340, P317, P321, P330, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information1-Propanamine, 3-(5H-dibenzoa,dcyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (89.1%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Cyclobenzaprine hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 6 items

CYCLOBENZAPRINE HCL

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

CYCLOBENZAPRINE HCL ER

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

CYCLOBENZAPRINE HYDROCHLORIDE

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

MeSH Pharmacological Classification · 3 items

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes.

Applications · 5 items

DescriptionCyclobenzaprine is a skeletal muscle relaxant that also has sedative properties. It has been shown to antagonize muscarinic receptors (Kis = 25, 60, and 6 nM for M1, M2, and M3, respectively), serotonin 5-HT2 receptors (Kis = 56 and 330 nM for 5-HT2C and 5-HT2B, respectively), and histamine H1 receptor (IC50 = 20 nM).

Related reactions

3 records
New reaction record
HRID 2061222 reaction equation
HRID 2061222As reactant
HRID 2236003 reaction equation
HRID 2236003As reactant
HRID 2374821 reaction equation
HRID 2374821As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
InChIKey
VXEAYBOGHINOKW-UHFFFAOYSA-N
SMILES
Cl.CN(C)CC\C=C1\c2ccccc2C=Cc3ccccc13
CAS DataBase Reference
6202 · 6202-23-9(CAS DataBase Reference)
FDA UNII
0 VE05JYS2P · 0VE05JYS2P
NCI Drug Dictionary
cyclobenzaprine hydrochloride
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301-H312+H332
Precautionary statements
280 · P280-P301+P310+P330-P302+P352+P312-P304+P340+P312
Hazard Codes
Xn,T,F
Risk Statements
20 · 20/21/22-39/23/24/25-23/24/25-11
Safety Statements
36 · 36-45-36/37-16-7
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
875000 · HP0875000
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29214990 · 29214990
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralAcute · Acute Tox. 3 OralAcute Tox. 4 DermalAcute Tox. 4 Inhalation
Toxicity
50 in · LD50 in mice (mg/kg): 35 i.v., 250 orally (Metysova)
wgk
3
rtecs
HP0875000
ridadr
UN 2811 6.1/PG 3
hs_code
29214990
Toxicity
LD50 in mice (mg/kg): 35 i.v., 250 orally (Metysova)
risk_code
20/21/22-39/23/24/25-23/24/25-11
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
Xn,T,F
safety_code
36-45-36/37-16-7
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301-H312+H332
Hazard Classifications
Acute Tox. 3 OralAcute Tox. 4 DermalAcute Tox. 4 Inhalation
Precautionary statements
P280-P301+P310+P330-P302+P352+P312-P304+P340+P312

UsesCyclobenzaprine hydrochloride can be used as a serotonin receptor inhibitor.

UsesCyclobenzaprine hydrochloride cam be used as muscle relaxant (skeletal).

UsesCyclobenzaprine hydrochloride has been used to study its effect on the muscles of dystrophin-deficient mdx5Cv mice.

General DescriptionCyclobenzaprine is a tricyclic agent, which has anti-depressant and anti-cholinergic properties. It lowers the tonic somatic motor activity of motor neuron systems. Cyclobenzaprine prevents the uptake ofnoradrenaline. It is used to treat neck,back and myofascial pain. Cyclobenzaprine functions as a nerve impulse inhibitor.

Upstream & downstream products

Upstream raw materials

Hydrochloric acid3-Chloro-1-(N,N-dimethyl)propylamine

Additional notes

DefinitionChEBI: The hydrochloride salt of cyclobenzaprine. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm.